All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAART-LX273 | Anti-Cytokeratin (A53-B/A2) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | A53-B/A2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX274 | Anti-Cytokeratin (A45-B/B3) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | A45-B/B3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX275 | Anti-Cytokeratin (CAM 5.2) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | CAM 5.2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX276 | Anti-Cytokeratin (KG 8.13) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | KG 8.13 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX277 | Anti-Cytokeratin (clone 80) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | clone 80 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX278 | Anti-Cytokeratin (OCS-1) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | OCS-1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX279 | Anti-Cytokeratin (AE1/AE3) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | AE1/AE3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX280 | Anti-Cytokeratin (EKH4) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | EKH4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX281 | Anti-Cytokeratin (A53-B/A2) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | A53-B/A2 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX282 | Anti-Cytokeratin (A45-B/B3) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | A45-B/B3 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX283 | Anti-Cytokeratin (CAM 5.2) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | CAM 5.2 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX284 | Anti-Cytokeratin (KG 8.13) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | KG 8.13 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX285 | Anti-Cytokeratin (clone 80) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | clone 80 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX286 | Anti-Cytokeratin (OCS-1) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | OCS-1 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX287 | Anti-Cytokeratin (AE1/AE3) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | AE1/AE3 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX288 | Anti-Cytokeratin (EKH4) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | EKH4 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION